Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 172

Sort by

Sort Order Select

Journal Articles

Blinatumomab maintenance after allogeneic hematopoietic cell transplantation for B-lineage acute lymphoblastic leukemia

Blood (2022) 139 (12): 1908–1919.

https://doi.org/10.1182/blood.2021013290

Published: 2022

Includes: Supplemental data

Journal Articles

A randomized phase 2 trial of idiotype vaccination and adoptive autologous T-cell transfer in patients with multiple myeloma

Blood (2022) 139 (9): 1289–1301.

https://doi.org/10.1182/blood.2020008493

Published: 2022

Includes: Supplemental data

Journal Articles

Allogeneic hematopoietic stem cell transplantation for MDS and CMML: recommendations from an international expert panel

Blood (2017) 129 (13): 1753–1762.

https://doi.org/10.1182/blood-2016-06-724500

Published: 2017

Includes: Supplemental data

Journal Articles

KIR gene haplotype: an independent predictor of clinical outcome in MDS patients

Blood (2016) 128 (24): 2819–2823.

https://doi.org/10.1182/blood-2016-05-713099

Published: 2016

Includes: Supplemental data

Journal Articles

IL-10 + regulatory B cells are enriched in cord blood and may protect against cGVHD after cord blood transplantation

Blood (2016) 128 (10): 1346–1361.

https://doi.org/10.1182/blood-2016-01-695122

Published: 2016

Includes: Supplemental data

Journal Articles

Specific combinations of donor and recipient KIR-HLA genotypes predict for large differences in outcome after cord blood transplantation

Blood (2016) 128 (2): 297–312.

https://doi.org/10.1182/blood-2016-03-706317

Published: 2016

Includes: Supplemental data

Journal Articles

Phase 3 trial of defibrotide for the treatment of severe veno-occlusive disease and multi-organ failure

Blood (2016) 127 (13): 1656–1665.

https://doi.org/10.1182/blood-2015-10-676924

Published: 2016

Includes: Supplemental data

Journal Articles

Outcomes of Haploidenitical Stem Cell Transplants for De Novo Acute Myeloid Leukemia, Myelodysplastic Syndrome and Acute Myeloid Leukemia Arising from MDS: The MD Anderson Experience

Reshma Ramlal, MD, Sameh Gaballa, MD, Julianne Chen, Gabriela Rondon, MD, Betul Oran, MD, Sairah Ahmed, MD, Qaiser Bashir, MD, Katayoun Rezvani, MD, PhD, David Marin, MD, Amin M. Alousi, MD, Partow Kebriaei, MD, Muzaffar Qazilbash, MD, Chitra Hosing, MD, Uday R. Popat, MD, Elizabeth J Shpall, MD, Richard Champlin, MD, Stefan O. Ciurea, MD

Blood (2015) 126 (23): 3225.

https://doi.org/10.1182/blood.V126.23.3225.3225

Published: 2015

Journal Articles

Cord Blood Derived Natural Killer Cells Engineered with a Chimeric Antigen Receptor Targeting CD19 and Expressing IL-15 Have Long Term Persistence and Exert Potent Anti-Leukemia Activity

Enli Liu, MD MS, Yijiu Tong, Gianpietro Dotti, MD, Barbara Savoldo, MD, Muharrem Muftuoglu, Kayo Kondo, PhD, Malini Mukherjee, Jordan S. Orange, MD PhD, Catherine Sobieski, Abdullah Alsuliman, Hila Shaim, MD, Nobuhiko Imahashi, MD PhD, Michael J. Keating, MD, Chitra M. Hosing, MD, Nina Shah, MD, William Wierda, MD PhD, Richard Champlin, MD, Elizabeth J. Shpall, MD, Katayoun Rezvani, MDPhD

Blood (2015) 126 (23): 3091.

https://doi.org/10.1182/blood.V126.23.3091.3091

Published: 2015

Journal Articles

CC-486 (Oral Azacitidine) Following Allogeneic Hematopoietic Stem Cell Transplantation (AlloHSCT) in Patients with Myelodysplastic Syndromes (MDS) or Acute Myeloid Leukemia (AML)

Basem M. William, MD, Marcos de Lima, MD, Betul Oran, MD, Richard Champlin, MD, Esperanza B Papadopoulos, MD, Sergio Giralt, MD, Bart L. Scott, MD, Joel Hetzer, PhD, Xiwei Wang, PhD, Eric Laille, MS, Barry S. Skikne, MD, Charles Craddock, MDPhD

Blood (2014) 124 (21): 990.

https://doi.org/10.1182/blood.V124.21.990.990

Published: 2014

Journal Articles

Regulatory B cells are enriched within the IgM memory and transitional subsets in healthy donors but are deficient in chronic GVHD

Blood (2014) 124 (13): 2034–2045.

https://doi.org/10.1182/blood-2014-04-571125

Published: 2014

Includes: Supplemental data

Journal Articles

Acute graft-versus-host disease: more than just alloreactivity

Richard Champlin

Blood (2014) 124 (2): 163–164.

https://doi.org/10.1182/blood-2014-05-575431

Published: 2014

Journal Articles

Multiple mismatches at the low expression HLA loci DP, DQ, and DRB3/4/5 associate with adverse outcomes in hematopoietic stem cell transplantation

Marcelo A. Fernández-Viña, John P. Klein, Michael Haagenson, Stephen R. Spellman, Claudio Anasetti, Harriet Noreen, Lee Ann Baxter-Lowe, Pedro Cano, Neal Flomenberg, Dennis L. Confer, Mary M. Horowitz, Machteld Oudshoorn, Effie W. Petersdorf, Michelle Setterholm, Richard Champlin, Stephanie J. Lee, Marcos de Lima

Blood (2013) 121 (22): 4603–4610.

https://doi.org/10.1182/blood-2013-02-481945

Published: 2013

Includes: Supplemental data

Journal Articles

The characteristics and outcomes of parainfluenza virus infections in 200 patients with leukemia or recipients of hematopoietic stem cell transplantation

Roy F. Chemaly, Santosh S. Hanmod, Dhanesh B. Rathod, Shashank S. Ghantoji, Ying Jiang, Arpan Doshi, Karen Vigil, Javier A. Adachi, Andrew M. Khoury, Jeffery Tarrand, Chitra Hosing, Richard Champlin

Blood (2012) 119 (12): 2738–2745.

https://doi.org/10.1182/blood-2011-08-371112

Published: 2012

Journal Articles

Improved survival in chronic myeloid leukemia since the introduction of imatinib therapy: a single-institution historical experience

Hagop Kantarjian, Susan O'Brien, Elias Jabbour, Guillermo Garcia-Manero, Alfonso Quintas-Cardama, Jenny Shan, Mary Beth Rios, Farhad Ravandi, Stefan Faderl, Tapan Kadia, Gautam Borthakur, Xuelin Huang, Richard Champlin, Moshe Talpaz, Jorge Cortes

Blood (2012) 119 (9): 1981–1987.

https://doi.org/10.1182/blood-2011-08-358135

Published: 2012

Journal Articles

Durable Responses with Autologous Hematopoietic Stem Cell Transplantation in Patients with POEMS Syndrome

Krina Patel, MD, Robert Z. Orlowski, MD, PhD, Nina Shah, MD, Qaiser Bashir, MD, Yvonne T Dinh, Gabriela Rondon, MD, Sergio Giralt, MD, Richard Champlin, MD, Muzaffar H Qazilbash, MD

Blood (2011) 118 (21): 4522.

https://doi.org/10.1182/blood.V118.21.4522.4522

Published: 2011

Journal Articles

Long Term Results of Allogeneic Stem Cell Transplantation for Myelodysplastic Syndrome: Analysis of Prognostic Factors

Uday Popat, M.D., Roland Bassett, Leandro de Padua Silva, Amin M Alousi, MD, Paolo Anderlini, MD, Chitra M Hosing, MD, Roy Jones, MD, PhD, Partow Kebriaei, MD, Issa Khouri, MD, Elizabeth J Shpall, MD, Muzaffar H Qazilbash, MD, Guillermo Garcia-Manero, Borje S Andersson, MD, PhD, Richard Champlin, MD, Marcos J de Lima, MD

Blood (2011) 118 (21): 4531.

https://doi.org/10.1182/blood.V118.21.4531.4531

Published: 2011

Journal Articles

A Comparative Study of the Outcome of High-Dose Therapy and Autologous Hematopoietic Stem Cell Transplantation in Patients with High-Risk or Standard-Risk Myeloma Treated Concurrently,

Syed Kazmi, MD, Gary Lu, MD, Nina Shah, MD, Qaiser Bashir, MD, Simrit Parmar, M.D., Robert Z. Orlowski, MD, PhD, Jatin J Shah, MD, Chitra M Hosing, MD, Uday Popat, M.D., Yvonne T Dinh, Sofia Qureshi, Gabriela Rondon, MD, Sergio Giralt, MD, Richard Champlin, MD, Muzaffar H. Qazilbash, MD

Blood (2011) 118 (21): 4156.

https://doi.org/10.1182/blood.V118.21.4156.4156

Published: 2011

Journal Articles

Phase I/II Trial of Fludarabine in Combination with Intravenous Busulfan and Allogeneic Progenitor Cell Support for Patients with High Risk Hematologic Malignancies; Dose Matters in Reduced Intensity Regimens

Simrit Parmar, M.D., Gabriela Rondon, MD, Peter F Thall, PhD, Roland Bassett, Marcos De Lima, MD, Chitra M Hosing, MD, Paolo Anderlini, MD, Partow Kebriaei, MD, Issa Khouri, MD, Prasanth Ganesan, MD, Yvonne A Efebera, M.D., Richard Champlin, MD, Sergio A Giralt, MD

Blood (2011) 118 (21): 1944.

https://doi.org/10.1182/blood.V118.21.1944.1944

Published: 2011

Journal Articles

Targeting Leukemias by CD123 Specific Chimeric Antigen Receptor

Radhika Thokala, MS, Harjeet Singh, PhD, Simon Olivares, BS, Richard Champlin, MD, Laurence J N Cooper, MD, PhD

Blood (2011) 118 (21): 1908.

https://doi.org/10.1182/blood.V118.21.1908.1908

Published: 2011

NARROW

Blinatumomab maintenance after allogeneic hematopoietic cell transplantation for B-lineage acute lymphoblastic leukemia

A randomized phase 2 trial of idiotype vaccination and adoptive autologous T-cell transfer in patients with multiple myeloma

Allogeneic hematopoietic stem cell transplantation for MDS and CMML: recommendations from an international expert panel

KIR gene haplotype: an independent predictor of clinical outcome in MDS patients

IL-10 + regulatory B cells are enriched in cord blood and may protect against cGVHD after cord blood transplantation

Specific combinations of donor and recipient KIR-HLA genotypes predict for large differences in outcome after cord blood transplantation

Phase 3 trial of defibrotide for the treatment of severe veno-occlusive disease and multi-organ failure

Outcomes of Haploidenitical Stem Cell Transplants for De Novo Acute Myeloid Leukemia, Myelodysplastic Syndrome and Acute Myeloid Leukemia Arising from MDS: The MD Anderson Experience

Cord Blood Derived Natural Killer Cells Engineered with a Chimeric Antigen Receptor Targeting CD19 and Expressing IL-15 Have Long Term Persistence and Exert Potent Anti-Leukemia Activity

CC-486 (Oral Azacitidine) Following Allogeneic Hematopoietic Stem Cell Transplantation (AlloHSCT) in Patients with Myelodysplastic Syndromes (MDS) or Acute Myeloid Leukemia (AML)

Regulatory B cells are enriched within the IgM memory and transitional subsets in healthy donors but are deficient in chronic GVHD

Acute graft-versus-host disease: more than just alloreactivity

Multiple mismatches at the low expression HLA loci DP, DQ, and DRB3/4/5 associate with adverse outcomes in hematopoietic stem cell transplantation

The characteristics and outcomes of parainfluenza virus infections in 200 patients with leukemia or recipients of hematopoietic stem cell transplantation

Improved survival in chronic myeloid leukemia since the introduction of imatinib therapy: a single-institution historical experience

Durable Responses with Autologous Hematopoietic Stem Cell Transplantation in Patients with POEMS Syndrome

Long Term Results of Allogeneic Stem Cell Transplantation for Myelodysplastic Syndrome: Analysis of Prognostic Factors

A Comparative Study of the Outcome of High-Dose Therapy and Autologous Hematopoietic Stem Cell Transplantation in Patients with High-Risk or Standard-Risk Myeloma Treated Concurrently,

Phase I/II Trial of Fludarabine in Combination with Intravenous Busulfan and Allogeneic Progenitor Cell Support for Patients with High Risk Hematologic Malignancies; Dose Matters in Reduced Intensity Regimens

Targeting Leukemias by CD123 Specific Chimeric Antigen Receptor

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only